• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ADAMTS-13在内皮细胞上对血管性血友病因子的裂解作用。

Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells.

作者信息

López José A, Dong Jing-fei

机构信息

Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

Semin Hematol. 2004 Jan;41(1):15-23. doi: 10.1053/j.seminhematol.2003.10.004.

DOI:10.1053/j.seminhematol.2003.10.004
PMID:14727255
Abstract

When histamine-stimulated endothelial cells are perfused with platelets in buffer, the platelets form long beads-on-a-string structures on the surface of the cells. The strands connecting the platelets are composed of ultralarge multimers of von Willebrand factor (ULVWF) and can be rapidly cleaved when perfused with normal plasma or purified ADAMTS-13 metalloprotease, but not with plasma from patients with either congenital or acquired thrombotic thrombocytopenic purpura (TTP). These ULVWF strings anchor to the surface of the endothelial cell at least partly through P-selectin, as their formation is prevented by either soluble P-selectin or P-selectin antibodies. They are also able to support the attachment of beads coated with ADAMTS-13. The metalloprotease binds to both the A1 and A3 domains of VWF, the latter with higher affinity. This attachment docks the enzyme close to its substrate site within the A2 domain. We propose that attachment of newly released ULVWF to the endothelial cell surface facilitates its cleavage by ADAMTS-13 by allowing tensile force to be applied to the A2 domain, thereby exposing the ADAMTS-13 cleavage site.

摘要

当用缓冲液中的血小板灌注组胺刺激的内皮细胞时,血小板会在细胞表面形成长的“串珠”结构。连接血小板的链由超大分子量的血管性血友病因子多聚体(ULVWF)组成,当用正常血浆或纯化的ADAMTS-13金属蛋白酶灌注时,这些链可迅速裂解,但用先天性或获得性血栓性血小板减少性紫癜(TTP)患者的血浆灌注时则不会裂解。这些ULVWF链至少部分通过P-选择素锚定在内皮细胞表面,因为可溶性P-选择素或P-选择素抗体可阻止其形成。它们还能够支持包被有ADAMTS-13的珠子的附着。金属蛋白酶与VWF的A1和A3结构域结合,与后者的亲和力更高。这种附着将酶对接至A2结构域内靠近其底物位点的位置。我们提出,新释放的ULVWF附着在内皮细胞表面,通过允许对A2结构域施加拉力,从而暴露ADAMTS-13裂解位点,促进其被ADAMTS-13裂解。

相似文献

1
Cleavage of von Willebrand factor by ADAMTS-13 on endothelial cells.ADAMTS-13在内皮细胞上对血管性血友病因子的裂解作用。
Semin Hematol. 2004 Jan;41(1):15-23. doi: 10.1053/j.seminhematol.2003.10.004.
2
ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor.ADAMTS-13金属蛋白酶与内皮细胞衍生的超大血管性血友病因子相互作用。
J Biol Chem. 2003 Aug 8;278(32):29633-9. doi: 10.1074/jbc.M301385200. Epub 2003 May 29.
3
ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.ADAMTS-13在流动条件下能迅速切割内皮表面新分泌的超大血管性血友病因子多聚体。
Blood. 2002 Dec 1;100(12):4033-9. doi: 10.1182/blood-2002-05-1401. Epub 2002 Jul 25.
4
von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.血管性血友病因子、含血小板解聚蛋白基序的金属蛋白酶13与血栓性血小板减少性紫癜
Semin Hematol. 2004 Jan;41(1):4-14. doi: 10.1053/j.seminhematol.2003.10.003.
5
[ADAMTS13-Mediated Proteolytic Cleavage of Unusually Large von Willebrand Factor Polymers on Endothelial Cells in the Absence of Fluid Shear Stress].[在无流体剪切应力情况下,ADAMTS13介导的内皮细胞上超大血管性血友病因子聚合物的蛋白水解切割]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Apr;32(2):532-540. doi: 10.19746/j.cnki.issn.1009-2137.2024.02.032.
6
Generation and breakdown of soluble ultralarge von Willebrand factor multimers.可溶性超大血管性血友病因子多聚体的生成和分解。
Semin Thromb Hemost. 2012 Feb;38(1):38-46. doi: 10.1055/s-0031-1300950. Epub 2012 Feb 7.
7
P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface.P选择素将新释放的超大血管性血友病因子多聚体锚定在内皮细胞表面。
Blood. 2004 Mar 15;103(6):2150-6. doi: 10.1182/blood-2003-08-2956. Epub 2003 Nov 20.
8
Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions.在流动条件下,ADAMTS - 13对超大血管性血友病因子的裂解作用。
J Thromb Haemost. 2005 Aug;3(8):1710-6. doi: 10.1111/j.1538-7836.2005.01360.x.
9
Shear stress and the role of high molecular weight von Willebrand factor multimers in thrombus formation.剪切应力以及高分子量血管性血友病因子多聚体在血栓形成中的作用。
Blood Coagul Fibrinolysis. 2005 Apr;16 Suppl 1:S11-6. doi: 10.1097/01.mbc.0000167657.85143.ad.
10
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.血管性血友病因子、ADAMTS13与血栓性血小板减少性紫癜
J Mol Med (Berl). 2002 Oct;80(10):639-47. doi: 10.1007/s00109-002-0369-8. Epub 2002 Sep 5.

引用本文的文献

1
Immune thrombotic thrombocytopenic purpura: pathogenesis and novel therapies: a narrative review.免疫性血栓性血小板减少性紫癜:发病机制与新疗法:一篇叙述性综述
Ann Blood. 2023 Sep 30;8. doi: 10.21037/aob-22-29. Epub 2023 Jan 6.
2
A novel mechanism underlying allosteric regulation of ADAMTS-13 revealed by hydrogen-deuterium exchange plus mass spectrometry.氢氘交换质谱法揭示的ADAMTS-13变构调节潜在新机制
Res Pract Thromb Haemost. 2022 Dec 13;7(1):100012. doi: 10.1016/j.rpth.2022.100012. eCollection 2023 Jan.
3
ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.
ADAM 和 ADAMTS 解整合素金属蛋白酶作为血管功能障碍和疾病的主要因素和分子靶点。
Adv Pharmacol. 2022;94:255-363. doi: 10.1016/bs.apha.2021.11.002. Epub 2022 Jan 24.
4
Targeting von Willebrand factor in liver diseases: A novel therapeutic strategy?靶向肝脏疾病中的血管性血友病因子:一种新的治疗策略?
J Thromb Haemost. 2021 Jun;19(6):1390-1408. doi: 10.1111/jth.15312. Epub 2021 May 3.
5
A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.血管生物学和疾病中的解整合素和金属蛋白酶(ADAM)及其含血小板反应蛋白基序的 ADAM(ADAMTS)家族。
Biochem Pharmacol. 2019 Jun;164:188-204. doi: 10.1016/j.bcp.2019.03.033. Epub 2019 Mar 21.
6
The role of von Willebrand factor in thrombotic microangiopathy.血管性血友病因子在血栓性微血管病中的作用。
Pediatr Nephrol. 2018 Aug;33(8):1297-1307. doi: 10.1007/s00467-017-3744-y. Epub 2017 Jul 26.
7
Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo.体内内皮细胞亚群中因子VIII和血管性血友病因子的表达模式
Blood. 2016 Jul 7;128(1):104-9. doi: 10.1182/blood-2015-12-684688. Epub 2016 May 12.
8
Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell disease.镰状细胞病患者急性胸综合征中的肺血小板血栓和血管病理学
Am J Hematol. 2016 Feb;91(2):173-8. doi: 10.1002/ajh.24224.
9
The application of vWF/ADAMTS13 in essential hypertension.血管性血友病因子/含凝血酶敏感蛋白基序的去整合素样金属蛋白酶13在原发性高血压中的应用
Int J Clin Exp Med. 2014 Dec 15;7(12):5636-42. eCollection 2014.
10
A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets.一种源自凝血因子VIII的肽能够使人工血小板纳米构建体与血管性血友病因子(VWF)结合,而不会干扰天然血小板与VWF的粘附。
Nanoscale. 2014 May 7;6(9):4765-73. doi: 10.1039/c3nr06400j.